Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

12,000 total articles

Director Fred Faching Liquidates $589K in Newegg Stock Over Two Days

Director Fred Faching Liquidates $589K in Newegg Stock Over Two Days

Fred Faching, a director and 10% shareholder of Newegg Commerce, Inc. (NASDAQ:NEGG), sold a total value of $589,390 worth of common stock over two trading days in late May 2026. The sales were managed through Tekhill USA LLC, where Faching is the sole member and manager. This activity occurs while Newegg shares are trading at $19.50, reflecting a s…

CEO's Sales and Company Performance Under Scrutiny at Fold Holdings

CEO's Sales and Company Performance Under Scrutiny at Fold Holdings

Fold Holdings CEO William Brian Poppic Reeves sold a total of $19,346 worth of shares over two days in May 2026. This transaction was noted as a 'sell to cover' required for tax withholding related to restricted stock units. The sales occurred against a backdrop of challenging financial reports for the first quarter of 2026, where both earnings per…

Insider Sales and Corporate Developments at Battalion Oil Signal Volatility Amid Operational Expansion

Insider Sales and Corporate Developments at Battalion Oil Signal Volatility Amid Operational Expansion

Major institutional shareholder Luminus Energy Partners Master Fund reported substantial sales of BATTALION OIL CORP (BATL) common stock in late March 2026. These transactions, which involved the disposition of over 3 million shares, occurred against a backdrop of significant price volatility for BATL. Concurrently, the company announced several st…

Insider Activity and Clinical Milestones at Cadrenal Therapeutics Provide Mixed Signals for Investors

Insider Activity and Clinical Milestones at Cadrenal Therapeutics Provide Mixed Signals for Investors

The CEO of Cadrenal Therapeutics, Pham Quang X, executed a stock sale valued at $6,628. This transaction occurred while the company reported key clinical progress with its drug candidate, CAD-1005, including an End-of-Phase 2 meeting with the FDA and planning for a Phase 3 trial. The stock's current valuation relative to the recent insider sale pri…

Partners Group Affiliates Liquidate Millions in Life Time Group Stock Amid Strong Performance Metrics

Partners Group Affiliates Liquidate Millions in Life Time Group Stock Amid Strong Performance Metrics

A collective group of entities associated with Partners Group sold a substantial amount of common stock in Life Time Group Holdings, Inc. (NASDAQ: LTH) on May 21, 2026. This transaction involved the disposition of 449,960 shares at $32.51 per share, generating proceeds totaling approximately $14.6 million. The sale occurred while LTH stock was trad…